Senior insider sale
Chief Medical Officer at REATA PHARMACEUTICALS INC — senior position signals high conviction
$513.6K
3.37K shares
What this filing means
MEYER COLIN JOHN plans to sell 3.37K shares of REATA PHARMACEUTICALS INC valued at approximately $513.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/16/2023ACC: 0001964306-23-000172
Officer· Chief Medical Officer
Since Jan 2019
3.37K
Shares to sell
$513.6K
Approx. market value
596.00
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Vesting of restricted stock unit award
Granted as part of issuer equity compensation plan
8/15/2023
596.00Total acquired596.00
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/15/2023 | Vesting of restricted stock unit award Granted as part of issuer equity compensation plan | 596.00 | — |
| Total | 596.00 | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
2.14K
Market value
$362.5K
8/15/2023
—Completed
Units to sell
625.00
Market value
$50.6K
5/16/2023
Planned — Approximate Date
NASDAQPlanned
Units to sell
596.00
Market value
$100.6K
8/16/2023
Total
Units
3.37K
Value
$513.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
8/15/2023 | 2.14K | $362.5K | — | Completed |
5/16/2023 | 625.00 | $50.6K | — | Completed |
| Planned — Approximate Date | ||||
8/16/2023 | 596.00 | $100.6K | NASDAQ | Planned |
| Total | 3.37K | $513.6K | ||